Fang Yuan. "Efficacy and safety of disitamab vedotin combined with toripalimab for cisplatin-refractory advanced penile cancer: A prospective single-center study (SAVE).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.5034